PTHvsARKGETF Comparison
VS
Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. PTH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, ARKG's top sector exposures are Healthcare. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.75% for ARKG. PTH is up 24.18% year-to-date (YTD) with +$131M in YTD flows. ARKG performs better with 60.61% YTD performance, and +$136M in YTD flows. Run a side-by-side ETF comparison of PTH and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PTH vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/08/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH ARKG | +1.24%+5.74% | +26.10%+41.47% | +24.18%+60.61% | +56.23%+84.14% | +74.28%+50.72% | +10.24%-43.73% |
| Flows | PTH ARKG | +$26M+$110M | +$142M+$210M | +$131M+$136M | +$138M+$151M | +$78M-$431M | -$151M-$2.19B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH ARKG | +28.96%+43.03% | +26.07%+44.26% | +26.02%+43.95% | +25.76%+46.35% |
| Max drawdown | PTH ARKG | -7.42%-13.89% | -11.91%-27.52% | -27.71%-46.41% | -49.87%-78.11% |
| Max drawdown duration | PTH ARKG | 40d32d | 140d126d | 353d882d | 1735d1825d |
Trading data
PTH | ARKG | |
Last sale 9/8/2026 at 7:59 PM | $61.71 | $46.31 |
| Previous close 09/08/2026 | $61.13 | $46.85 |
| Consolidated volume 09/08/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexPTH | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/8/2026 at 7:59 PM
Live
Closed
PTH | ARKG | |
|---|---|---|
| Last price | $61.71 | $46.31 |
| 1D performance | +0.95% | -1.16% |
| AuM | $288.30 M | $1.99 B |
| E/R | 0.72% | 0.75% |
Characteristics
PTH | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | Ark Investment |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | - |
| N° of holdings | 54 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
PTH
USA
89.98%
Other
10.02%
ARKG
USA
88.43%
Other
11.57%
Sectors
PTH
Healthcare
99.16%
Other
0.84%
ARKG
Healthcare
97.99%
Other
2.01%
Diversification
PTH
Total weight of top 15 holdings out of 15
47.09%
ARKG
Total weight of top 15 holdings out of 15
75.55%
Top 15 holdings
Data as of July 31, 2026
PTH
Roivant Sciences Ltd.
4.88%
Revolution Medicines, Inc.
4.85%
BrightSpring Health Services, Inc.
4.77%
Guardant Health, Inc.
4.50%
Axsome Therapeutics, Inc.
4.38%
Liquidia Corp.
3.17%
Erasca, Inc.
2.92%
Oruka Therapeutics, Inc.
2.54%
10X Genomics, Inc.
2.27%
Relay Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.18%
Agilon Health, Inc.
2.13%
Oscar Health, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.09%
Tango Therapeutics, Inc.
2.09%
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
Frequently asked questions about PTH and ARKG
How have the PTH and ARKG ETFs performed in 2026?
As of September 8, 2026, PTH is up 24.18% year-to-date (YTD), while ARKG has returned 60.61%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: PTH or ARKG?
Year-to-date, the PTH ETF saw +$131M in flows, compared to +$136M for ARKG.
Which ETF is more volatile: PTH or ARKG?
Over the past year, PTH had a volatility of 26.07%, while ARKG experienced 44.26%.
Which ETF is bigger: PTH or ARKG?
As of September 8, 2026, PTH holds $288.30 M in assets under management (AUM), while ARKG manages $1.99 B.
What sectors do the PTH and ARKG ETFs invest in?
PTH leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the PTH ETF and ARKG ETF?
PTH top holdings include Roivant Sciences Ltd., Revolution Medicines, Inc. and BrightSpring Health Services, Inc.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: PTH or ARKG?
PTH holds 54 securities with 47.09% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 75.55%.
Advertisement
Latest news about PTH & ARKG
Continued tightening of the U.S. labor market
September 23, 2022
PTH
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
